Pfizer: Challenges Loom Amid Overvaluation

Pfizer Inc. 's (NYSE: PFE ) stock price continued stagnating over the last three months, which reinforces my cautious stance I discussed in November . Despite being one of a few companies that helped to save theComing from an IT background, I have dived into the U.S. stock market seven years ago by managing portfolio of my family. Starting managing real money has been challenging for the first time, but long hours of mastering fundamental analysis of public companies paid off and now I feel very confident i ...